Accumulating evidence has indicated that DMXAA is a STING agonist that can exert potent adjuvant and anti-tumor activities in mice, but not in humans due to its inability to activate the human STING pathway (5, 6, 8, 22). The gene discussed is STING1; the disease is neoplasm.